PPT-Alzheimer’s Disease Neuroimaging Initiative (ADNI)

Author : jane-oiler | Published Date : 2019-12-25

Alzheimers Disease Neuroimaging Initiative ADNI Ronald C Petersen PhD MD CoDirector Clinical Core Mayo Clinic College of Medicine Rochester MN Alzheimers Disease

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Alzheimer’s Disease Neuroimaging Initi..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Alzheimer’s Disease Neuroimaging Initiative (ADNI): Transcript

Alzheimers Disease Neuroimaging Initiative ADNI Ronald C Petersen PhD MD CoDirector Clinical Core Mayo Clinic College of Medicine Rochester MN Alzheimers Disease International Toronto March 28 2011. 學號：. A0128304 . 姓名. ：柯雅倫 . Allen. . (. 組長. ). 學號：. A0128310 . 姓名. ：王宜惠 . May. 學號：. A0128380 . 姓名. ：. 王. . 一 . Vic. 學號：. A0128381 . Andy Saykin. WW-ADNI Meeting. London, UK. July 14, 2017. asaykin@iupui.edu. Overview and 2017 Updates. ADNI-3 sample collection (banked at NCRAD). Longitudinal DNA & RNA (12 new, 79 continuing). Changes in ADNI-3 include PBMC and RBC collection. AAIC 2017. Presenter: Dr. Patricio . Chrem. . On . Behalf of:. Dr. Prof Ricardo Allegri (PI) . Dr. Gustavo Sevlever. July 14. th. , 2017. Arg. -ADNI. Patients’ Flowchart. Patients Screened at FLENI. Initiative . December, 2010. NEED FOR VALIDATED BIOMARKERS FOR AD TRIALS. Biomarkers useful in Phase 2 to make decisions about Phase 3 (e.g. doses). Biomarkers useful in Phase 3. Provide additional evidence to support primary outcome findings. 620 South 76th Street, Suite 160800.272.3900 4.479.8819faxMilwaukee, WI 53214alz.org/sewi .272390024/7 elpline The StatisticalanalysesTofindtheassociationofCSFBACEwiththegeneticpoly-morphism,aseparateGWASwasperformedusingPLINKsoftwareunderanadditivegeneticmodel.ThethresholdsofP05andP08wereusedforsuggesti Leslie M Shaw and John Q Trojanowski. WW ADNI meeting. Chicago, July 20, 2018. CSF. Ser. + . Pla. TOTAL. ADNI 1 Primary . Biofluids. Collected. 1118. 9756. 10874. ADNI . 1 Aliquots in Bank. 24934. Studies show early diagnosis may save USD 10-12K per patient. Study 1 – University of Wisconsin. Stage. Highest benefits at early stages (MMSE* 28). Costs. Drug therapy (acetylcholinesterase inhibitor). John C. Morris, . MD. On behalf of MW Weiner, L Beckett, T . Benzinger. , . D . Coble, . AM Fagan, BA Gordon, P . Massoumzadeh. , L . McCue, . N . Saito, . L Shaw, C . Xiong. , . VD Buckles, . and all Dominantly Inherited Alzheimer Network (DIAN) and Alzheimer Disease Neuroimaging Initiative (ADNI) Investigators. Silvia Vázquez, Deborah R. . Gustafson. , . Salvador M. Guinjoan, . Ricardo F. Allegri. and . Arg. -ADNI . group. .. Memory and Aging Center. Institute for Neurological Research . (FLENI. ) . Buenos Aires, Argentina. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward . Funded MRI Investigators. Partnerships to connect . knowledge. . and . e. nable a systems . a. pproach. Deeper understanding of metabolic failures across trajectory of disease. MOVE AD. ADNI GO/2. ADNI I. baseline. Rush Supplement. disease . It is . a degenerative brain disorder of unknown etiology which is the most common form of . dementia.. usually . starts in late middle age or in old age, results in progressive memory loss, impaired thinking, disorientation, and changes in personality and mood. . Cliff Jack. Bret Borowski . Matt Bernstein. Arvin Forghanian-Arani . Jeff Gunter. Dave Jones . Kejal Kantarci. Rob Reid . Denise Reyes . Matt Senjem. Kaely Thostenson. Prashanthi Vemuri . Chad Ward .

Download Document

Here is the link to download the presentation.
"Alzheimer’s Disease Neuroimaging Initiative (ADNI)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.